The DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Association between Blood Pressure and Serum Thyroid-Stimulating Hormone Concentration within the Reference Range: A Population-Based Study
Abstract
CONTEXT: The association between thyroid function and blood pressure is insufficiently studied. OBJECTIVE: The objective of the investigation was to study the association between TSH within the reference range and blood pressure. DESIGN AND SETTING: This was a cross-sectional, population-based study. SUBJECTS: A total of 30,728 individuals without previously known thyroid disease were studied. MAIN OUTCOME MEASURES: The main outcome measures were mean systolic and diastolic blood pressure and pulse pressure and odds ratio for hypertension (>140/90 mm Hg or current or previous use of antihypertensive medication), according to categories of TSH. RESULTS: Within the reference range of TSH (0.50-3.5 mU/liter), there was a linear increase in blood pressure with increasing TSH. The average increase in systolic blood pressure was 2.0 mm Hg [95% confidence interval (CI) 1.4-2.6 mm Hg] per milliunit per liter increase in TSH among men, and 1.8 mm Hg (95% CI 1.4-2.3 mm Hg) in women. The corresponding increase in diastolic blood pressure was 1.6 mm Hg (95% CI 1.2-2.0 mm Hg) in men and 1.1 mm Hg (95% CI 0.8-1.3 mm Hg) in women. Comparing TSH of 3.0-3.5 mU/liter (upper part of the reference) with TSH of 0.50-0.99 mU/liter (lower part of the reference), the odds ratio for hypertension was 1.98 (95% CI 1.56-2.53) in men and 1.23 (95% CI 1.04-1.46) in women. CONCLUSION: Within the reference range of TSH, we found a linear positive association between TSH and systolic and diastolic blood pressure that may have long-term implications for cardiovascular health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within the reference range of 0.50–3.5 mU/L, blood pressure increased linearly with increasing TSH (SBP by 2.0 mmHg in men and 1.8 mmHg in women, DBP increased by 1.6 and 1.1 mmHg) (101).”
From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [101]
In the citing paper
“For instance, comparing TSH of 3.0–3.5 mU/L with 0.50–0.99 mU/L, the OR for hypertension was 1.98 in men and 1.23 in women (101).”
From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [101]
In the citing paper
“In particular higher levels of TSH were associated with worsening of both blood pressure [58–60] and lipid levels [61, 62] although these effects were modest.”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [59]
Citations
Cites
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Hypothyroidism and Atherosclerosis
Cappola, A. R., & Ladenson, P. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030398 · Cited by 640
The Nord-Trøndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation
Holmen, J., Midthjell, K., Krüger, Ø., Langhammer, A., Holmen, T. L., Bratberg, G. H., Vatten, L., & Lund‐Larsen, P. G. (2003) · Cited by 526
Bjøro, T., Holmen, J., Krüger, Ø., Midthjell, K., Hunstad, K., Schreiner, T., Sandnes, L., & Brochmann, H. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430639 · Cited by 463
Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D., Ghiadoni, L., Salvetti, A., Ferrannini, E., & Monzani, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030039 · Cited by 431
Åsvold, B. O., Vatten, L. J., Nilsen, T. I. L., & Bjøro, T. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02333 · Cited by 350
Self-citationThe Thyrotropin Reference Range Should Remain Unchanged
Surks, M. I., Goswami, G., & Daniels, G. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0170 · Cited by 287
Risk Factors for Cardiovascular Disease in Women with Subclinical Hypothyroidism
Luboshitzky, R., Aviv, A., Herer, P., & Lavie, L. (2002) · Thyroid · doi:10.1089/105072502760043512 · Cited by 238
Lekakis, J. P., Papamichael, C. M., Alevizaki, M. K., Gd, P., MARAFELIA, P., Mantzos, J. D., Stamatelopoulos, S., & Koutras, D. A. (1997) · Thyroid · doi:10.1089/thy.1997.7.411 · Cited by 236
Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension.
Streeten, D. H., Anderson, G. H., Howland, T., Chiang, R., & Smulyan, H. (1988) · Hypertension · doi:10.1161/01.hyp.11.1.78 · Cited by 172
Flagged first, then by citations
2 of the 29 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–215 of 215
Amin, A. (2017) · Journal of Lung Pulmonary & Respiratory Research · doi:10.15406/jlprr.2017.04.00114
Вацеба, Т. С. (2017) · Bukovinian Medical Herald · doi:10.24061/2413-0737.xxi.2.82.1.2017.1
Hypertension in Thyroid Disorders
Kotsis, V., & Antza, C. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_32
Kim, H. J., Park, H. K., Byun, D. W., Suh, K., Yoo, M. H., Kim, J. H., Min, Y., Kim, S. W., & Chung, J. H. (2015) · Endocrine Abstracts · doi:10.1530/endoabs.37.ep1034
WITHDRAWN: Radiation induced hypothyroidism – Why is early intervention necessary?
Aggarwal, K., Thakur, S., Shetty, S. S., & Rao, V. U. S. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104442
RetractedThyroid Genetics and the Cardiovascular System
Kuś, A., Teumer, A., Chaker, L., & Medici, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_15
Individualized prevention in cardiovascular disease and diabetes mellitus
de Vries, T. I. (2020) · doi:10.33540/352
Nurcahyani, Y. D., Kumorowulan, S., Sukandar, P. B., Latifah, L., & Martiyana, C. (2021) · Medico-Legal Update · doi:10.37506/mlu.v21i3.2972
Abdulateef, D. S., Mahwi, T., Omer, S., & Abdullah, S. (2021) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10305
Hipotiroidismo subclínico e risco cardiovascular em mulheres idosas
Peterson, J. C. B. (2012) · doi:10.47749/t/unicamp.2012.872398
Modification of TSH-related genetic effects by indicators of socioeconomic position
Drogge, S.-C., Frank, M., Girschik, C., Jöckel, K., Führer‐Sakel, D., & Schmidt, B. (2022) · Endocrine Connections · doi:10.1530/ec-22-0127
Predictors of Serum TSH in a Healthy Adult Sample of the Lebanese Population
Achkar, A., Mourad, D., Naous, E., Sleilaty, G., & Gannagé‐Yared, M. (2022) · Annals of Thyroid Research · doi:10.26420/annalsthyroidres.2022.1089
Ahmad, N., Iqbal, S., Ahmad, M., Farooque, I., Khatoon, T., Gupta, A., & Ahmad, T. (2024) · Journal of Medical and Scientific Research · doi:10.17727/jmsr.2024/12-29
Blood electrolyte levels and renal functions in the regulation of blood pressure
Ali, S. N., & Alaubydi, M. A. (2025) · AIP conference proceedings · doi:10.1063/5.0290406
Duan, Y., Xu, C., Zhao, Q., Gu, J. F., Zhang, J., Zhuo, Y., & Zhang, H. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm46009
Metadata
- Authors
- Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., & Vatten, L. J.
- Affiliations
- Department of Public Health (B.O. Å., T.I.L.N., L.J.V.), Faculty of Medicine, Norwegian University of Science and Technology, N-7489 Trondheim, Norway
- Oslo University Hospital (NO)
- Norwegian University of Science and Technology (NO)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-03-01
- Volume
- 92
- Issue
- 3
- Pages
- 841-845
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2079601862
- Cited by
- 215
- References
- 29
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 13 · 2021: 9 · 2020: 15 · 2019: 15 · 2018: 17 · 2017: 8 · 2016: 13 · 2015: 12 · 2014: 15 · 2013: 11 · 2012: 18
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Norwegian Institute of Public Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- thyroid-stimulating hormone, blood pressure, hypertension, thyroid function, reference values, systolic blood pressure, diastolic blood pressure, pulse pressure, cardiovascular health
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Pressure, Cross-Sectional Studies, Female, Health Surveys, Humans, Hypertension, Male, Middle Aged, Norway, Reference Values, Thyrotropin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review